Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic pathways of ischaemic preconditioning and postconditioning in myocardial injury
ISRCTN49989273Phase 3Completed
- Sponsor
- University College London
- Start
- Jun 2007
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
01
Overview
Phase 3 trial of cyclosporine, atorvastatin and erythropoietin in Myocardial injury, myocardial infarction (MI) and cardiac morbidity (3 arms), sponsored by University College London. Primary endpoints: Serum cardiac troponin T and Creatine kinase-MB. Started Jun 2007; status: completed.
02
Drugs
cyclosporineatorvastatinerythropoietin
03
Conditions
Myocardial injurymyocardial infarction (MI)cardiac morbidity
Beyond the preview
Go deeper on ISRCTN49989273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN49989273.